|
2025
|
P/S
|
Pharmaceutical preparations for the treatment of neurologic disorders. Providing medical informat... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of neurologic disorders Providing medical informati... |
|
|
Invention
|
Method for reducing flu-like symptoms associated with intramuscular administration of interferon ... |
|
|
Invention
|
Glycogen synthase kinase 3 inhibitors and uses thereof.
The present disclosure provides compound... |
|
|
Invention
|
Methods of treating or preventing spinal muscular atrophy.
Featured are methods for the treatmen... |
|
|
Invention
|
Aav capsids comprising anti-transferrin antibody domains. The present disclosure pertains to targ... |
|
|
Invention
|
Anti-transferrin receptor antibodies and uses thereof. Provided herein are single chain antibody ... |
|
|
Invention
|
Aav capsids for targeting human transferrin receptor. The present disclosure pertains to targetin... |
|
|
Invention
|
N-[4-fluor-5-[[(2s, 4 r)-4-[(6-methoxy-4-pyrimidinyl)oxy]- 2-methyl-1-pyrrolidinyl] methyl ]-2-th... |
|
|
Invention
|
Pharmaceutical compositions and dosage regimens for clinical use of anti-blood dendritic cell ant... |
|
|
Invention
|
Methods for treating spinal muscular atrophy. The present disclosure provides a method of treatin... |
|
|
Invention
|
Anti-blood dendritic cell antigen 2 antibodies and uses thereof.
Antibodies and antibody fragmen... |
|
2024
|
Invention
|
Heterocyclic compounds of formula (i) for use in the treatment of spinal muscular atrophy via mod... |
|
|
Invention
|
Compounds for treating spinal muscular atrophy and huntington's disease. The present disclosure p... |
|
|
Invention
|
Tyk2 inhibitors. This disclosure relates to compounds of formula (I), or pharmaceutically accepta... |
|
|
Invention
|
Redirection of aav capsids for central nervous system targeting. The present disclosure pertains ... |
|
|
Invention
|
Methods for identifying aav capsid variants with desired characteristics. The present disclosure ... |
|
|
Invention
|
Anti-transferrin receptor antibodies and uses thereof. The present disclosure provides anti-trans... |
|
|
Invention
|
Anti-bcma antibodies.
This invention provides antibodies that recognize the B Cell Maturation An... |
|
|
Invention
|
Methods for evaluating patients.
Methods for evaluating subjects having conditions associated wi... |
|
|
Invention
|
Methods for treating alzheimer's disease. A method for treatment of a human subject for Alzheimer... |
|
|
Invention
|
Emopamil-binding protein inhibitors and uses thereof. Provided are compounds of Formula (I), or p... |
|
|
Invention
|
Emopamil-binding protein inhibitors and uses thereof. Provided are compounds of the Formula (I): ... |
|
|
Invention
|
Pyrimidinyl tyrosine kinase inhibitors.
The present invention provides compounds and composition... |
|
|
Invention
|
Method of assessing risk of pml.
The invention relates to methods of assessing a patient's risk ... |
|
|
Invention
|
Indole and pyrroloypyridine derivatives as gpr17 modulators. Disclosed is a compound represented ... |
|
|
Invention
|
Medical device having non-filtered csf withdrawal pathway.
An implantable medical device for del... |
|
|
Invention
|
Hydrophobic interaction chromatography for purification of oligonucleotides.
The present inventi... |
|
|
Invention
|
Glycogen synthase kinase 3 inhibitors and uses thereof. The present disclosure provides compounds... |
|
|
Invention
|
Method of assessing risk of pml. The invention relates to methods of assessing a patient' s risk ... |
|
|
Invention
|
Combination of a btk inhibitor and a fumaric acid ester for use in the treatment of multiple scle... |
|
|
Invention
|
Btk inhibitor for treating multiple sclerosis. The present disclosure provides methods of treatin... |
|
|
P/S
|
Pharmaceutical preparations for use in the treatment of psychiatric diseases and disorders, namel... |
|
|
Invention
|
Methods and products for evaluating an immune response to a therapeutic protein.
The invention r... |
|
2023
|
Invention
|
Methods of treating inflammatory and autoimmune diseases.
Natalizumab is a safe and efficacious ... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of neurological, neuromuscular, neuropsychiatric, p... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of
neurological, neuromuscular, neuropsychiatric, ... |
|
|
P/S
|
Pharmaceutical preparations; pharmaceutical preparations for use in the treatment of psychiatric ... |
|
|
Invention
|
Tyk2 inhibitors.
This disclosure relates to compounds of formula (I), or pharmaceutically accept... |
|
|
Invention
|
Crystalline polymorphs of n-methyl-n-((1s,3s)-3-methyl-3-((6-(1-methyl-1h-pyrazol-4-yl)pyrazolo[1... |
|
|
Invention
|
Diroximel fumarate synthesis.
Disclosed is a one-pot process (without the isolation of three int... |
|
|
P/S
|
pharmaceutical preparations for the treatment of neurological, neuromuscular, neuropsychiatric, p... |
|
|
P/S
|
Pharmaceutical preparations; pharmaceutical preparations for
use in the treatment of psychiatric... |
|
|
Invention
|
Emopamil-binding protein inhibitors and uses thereof.
Provided are compounds of the Formula (I):... |
|
|
Invention
|
Emopamil-binding protein inhibitors and uses thereof.
Provided are compounds of the Formula (I) ... |
|
|
P/S
|
Computer software for neuro-psychology tests; computer software for use to detect neurological di... |
|
2022
|
Invention
|
Modified actrii proteins and methods of use thereof.
An isolated protein comprising a mutant sol... |
|
|
Invention
|
Methods and systems for transfecting host cells.
The present disclosure pertains to methods for ... |
|
|
Invention
|
Formulations comprising fab-peg.
The present invention relates to the field of pharmaceutical co... |
|
|
Invention
|
Method for detecting a lipidated protein via fluorescence resonance energy transfer (fret).
Aspe... |
|
|
Invention
|
Btk inhibitors.
Provided are compounds of Formula (I) or pharmaceutically acceptable salts there... |
|
|
Invention
|
Btk inhibitors.
Provided are compounds of Formula (I): or pharmaceutically acceptable salts ther... |
|
|
Invention
|
Methods for treating alzheimer's disease.
Provided are methods for treating Alzheimer's disease ... |
|
|
Invention
|
Diroximel fumarate particles having improved flow properties and methods of making same.
Many ac... |
|
|
Invention
|
Methods for reducing tau expression.
Provided herein are methods of administering ISIS 814907 fo... |
|
|
P/S
|
Medical apparatus and instruments, namely, auto injection devices for pharmaceuticals |
|
|
Invention
|
Compounds for targeting degradation of irak4 proteins.
This disclosure relates to compounds of F... |
|
|
P/S
|
Medical diagnostic reagents and assays for testing of body fluids |
|
|
Invention
|
Tyk2 inhibitors.
This disclosure relates to compounds of formula (I′), or pharmaceutically accep... |
|
2021
|
Invention
|
2h-indazole derivatives as irak4 inhibitors and their use in the treatment of disease.
This disc... |
|
|
P/S
|
Providing medical and health information in the field of neurology and neurologic disorders. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis and other neurolog... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis |
|
|
P/S
|
Providing medical and health information in the field of neurology and neurologic disorders |
|
|
P/S
|
Pharmaceutical preparations for the treatment of
neurological disorders; pharmaceutical preparat... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of neurological disorders; pharmaceutical preparati... |
|
|
P/S
|
Providing educational information, webcasts, and training materials in the fields of health, medi... |
|
2020
|
P/S
|
Pharmaceutical preparations for the treatment of neurologic disorders Providing medical and healt... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of neurologic disorders; Pharmaceutical preparation... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of neurological and neurodegenerative diseases. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of choroidal diseases and disorders; pharmaceutical... |
|
|
P/S
|
Providing webcasts in the fields of health, medical conditions, and treatments; development and d... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of amyotrophic
lateral sclerosis and other neurolo... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of neurological disorders, namely, Alzheimer's Dise... |
|
|
P/S
|
Providing medical information in the field of neuromuscular diseases. |
|
|
P/S
|
Providing health information in the field of inflammatory disorders, namely, providing patient su... |
|
|
P/S
|
Pharmaceutical preparations. |
|
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of disorders of the central and peri... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical pre... |
